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a b s t r a c t
The L6 region of bovine adenovirus 3 (BAdV-3) encode 33K (spliced) and 22K (unspliced) proteins.
Earlier, anti-33K serum detected ﬁve major and three minor proteins in BAdV-3 infected cells. Here, we
demonstrate that anti-sera raised against L6-22K protein detected two proteins of 42 and 37 kDa in
BAdV-3 infected cells and one protein of 42 kDa in transfected cells expressing splice-site variant 22K
protein (pC.22K containing substituted splice acceptor/donor sequence). Unlike 22K, 33K stimulated the
transcription from the major late promoter (MLP) by binding to the downstream sequence elements
(DE). Analysis of the variant proteins demonstrated that amino acids 201–240 of the conserved C-
terminus of 33K containing the potential leucine zipper and RS repeat are required for the activation of
MLP. Furthermore, amino acid substitution analysis demonstrated that unlike arginine residues of RS
repeat, the leucine residues (217, 224, 232 and 240) of the conserved leucine zipper appear required for
the binding of 33K to the MLP.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Adenoviruses contain a non-enveloped, double-stranded DNA
genome of 26–45 kb with a GþC content of 33–63% (Davison et al.,
2000). The adenovirus genome is organized into complex transcrip-
tional units comprising of early, intermediate and late regions.
Expression of the early and intermediate transcription units precedes
the onset of viral DNA replication. However, expression of the late
transcription units is dependent on the initiation of viral DNA
replication and expression of the major late transcription unit (MLTU),
which is controlled by the major late promoter (MLP) (Thomas and
Mathews, 1980). The late transcriptional units encode structural and
nonstructural proteins involved in the formation of progeny virions.
Bovine adenovirus (BAdV)-3 is a member of subgroup I of BAdVs
and is being developed as a potential vector for animal vaccines (Baxi
et al., 2001; Zakhartchouk et al., 1999; 2004) and human gene delivery
(Rasmussen et al., 1999). Complete DNA sequence of the BAdV-3
genome has already been reported (Reddy et al., 1998). Like human
adenovirus (HAdV)-5, the BAdV-3 genome is organized into early,
intermediate, and late regions (Reddy et al., 1998). Unlike HAdV-5, the
late region of BAdV-3 genome is organized into seven regions, L1–L7
(Reddy et al., 1998). The L6 region of the late transcription unit of
BAdV-3 encodes 33K and 22K protein (Kulshreshtha, 2009; Reddy et
al., 1998). Earlier, using anti-33K serum we detected three proteins of
42 kDa, 38 kDa and 33 kDa (Kulshreshtha et al., 2004). The L6 33K
protein is a product of a spliced transcript, while 22K protein is
translated from the unspliced form of this transcript (Kulshreshtha,
2009; Reddy et al., 1998). The 33K and 22K proteins share a N-
terminus region of 138 amino acids (Kulshreshtha, 2009) and play an
important role in virus assembly (Kulshreshtha et al., 2004).
Recently, adenovirus 33K protein has been shown to be involved in
different steps of virus infection (Wu et al., 2013) including early to late
switch of major late transcription unit expression (Farley et al., 2004),
alternative RNA splicing factor (Tormanen et al., 2006), a transcrip-
tional activator (Ali et al., 2007) and packaging of viral genome in
empty capsid (Finnen et al., 2001;Wu et al., 2013). In this report, we
demonstrate that a highly conserved C-terminus region of BAdV-3 33K
protein contains domain required for binding to bovine MLP
sequences. Moreover, conserved leucine residues (amino acids 217,
224, 232, 240) located in this conserved region of bovine adenovirus-3
33K are important for binding of 33K to major late promoter.
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Results
Expression of BAdV-3 22K protein
The BAdV-3 22K protein (translated from unspliced form of 33K
transcript) shares N-terminal 138 amino acids with 33K protein
(translated from spliced form of 33K transcript) (Kulshreshtha et
al., 2004). Earlier, we reported the characterization of protein
(s) encoded by spliced form of BAdV-3 33K mRNA using anti-33Kp
serum raised against peptides representing unique C-terminal
region (amino acid 141–185 and 156–200) of 33K (spliced form
of 33K) protein (Kulshreshtha et al., 2014). To characterize BAdV-3
22K protein, we raised rabbit antisera against a peptide represent-
ing unique region of (amino acids 191–241) of 22K protein. As
expected, anti-33Kp sera detects protein of 42 kDa (Fig. 1, panel B)
in cells transfected with pC.33K DNA (Fig. 1, panel B). Surprisingly,
anti-33Kp serum also detected a major protein of 39 kDa in the
cells (Fig. 1, panel B) transfected with plasmid pC.22K DNA
(expressing unspliced form of 33K mRNA) (Fig. 1, panel A) or
plasmid pC.22KS1 DNA (pC.22K containing stop codon in the
unique region) (Fig. 1, panel A). No such protein could be detected
in cells (Fig. 1, panel B) transfected with plasmid pC.22Kss DNA
(pC.22K containing substitutions in splice acceptor/donor
sequence) (Fig. 1 panel A) or plasmid pCDNA3 DNA (Fig. 1 panel A).
To analyze the expression of 22K protein, we raised antisera (anti-
22Kp) against a peptide representing the unique C-terminal region
(amino acid 91–241) of 22K protein. Interestingly, sera raised against
L6-22K protein detected two major proteins of 42 kDa, and 37 kDa in
BAdV-3 infected cells at 48 h post infection (Fig. 1, panel C). Anti-
22Kp serum detected a protein of 42 kDa (Fig. 1, panel C) in cells
transfected with plasmid pC.22Kss DNA (Fig. 1, panel A). No such
protein(s) could be detected in cells (Fig. 1, panel C) transfected with
plasmid pC.33K DNA, plasmid pC.22K DNA, plasmid pC.22KS1 DNA
or plasmid pCDNA3 DNAs (Fig. 1 panel A).
Activation of transcription from major late promoter by BAdV-3 33K
protein
To investigate if BAdV-3 33K protein activate transcription from
major late promoter (MLP), initially we used plasmid pC.33K
expressing BAdV-3 33K (spliced form of 33K mRNA;
Kulshreshtha et al., 2014) and plasmid pC.IVa2 expressing full
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Fig. 1. Analysis of BAdV-3 22K protein. Schematic representation of BAdV-3 33K and 22K. The coding sequences shared by 33K and 22K ( ), unique region of 33K
( ), unique region of 22K ( ) and the spliced region of 33K ( ) are depicted. Human cytolmegalovirus immediate early promoter (CMV). The wild-type
(GT—AG) and mutated (GC—CG) splice acceptor/donor sites are depicted. The amino acid numbers are shown on top while nucleotide numbers are shown at the bottom. The
star represents the stop codon. The name of the plasmid is depicted on the right of the panel. (B, C) Western blot. Proteins from the lysates of BAdV-3 infected MDBK cells or
plasmid transfected 293T cells were separated by 10% SDS-PAGE, transferred to nitrocellulose membranes and probed with ant-33Kp sera (panel B) (Kulshreshtha et al.,
2014) or anti-22Kp sera (panel C). The molecular weight (in kDa) of proteins is depicted on the right of the panel.
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length BAdV-3 IVa2 (Tekele and Tikoo, unpublished data) as
positive control (Lutz and Kedinger, 1996). Western blot analysis
indicated that the cells transfected with individual plasmid pC.33K
(Fig. 2, panel A) or pC.IVa2 (Fig. 2, panel A) DNAs synthesized
proteins of expected molecular weight (Fig. 2, panels B,C). Next,
plasmid pMLP.Luc containing a luciferase reporter gene under the
control of MLP (Fig. 1A) was co-transfected into HeLa cells together
with individual plasmid pC.33K or plasmid pC.IVa2 (Fig. 1A) DNA.
As seen in Fig. 2D, luciferase expression increased 12 to 15-fold
when the cells were co-transfected with plasmid pMLP.
LucþpC.33K or pMLP.LucþpC.IVa2 DNAs (Fig. 2, panel D). How-
ever, there was no increase in the luciferase expression when the
cells were co-transfected with plasmid pMLP.LucþpCDNA3 DNAs
(Fig. 2, panel D). These results suggested that BAdV-3 33K activate
transcription from MLP.
Analysis of 33K protein sequences ofMastadenoviruses infecting
humans and different animals identiﬁed a highly conserved region
in BAdV-3 33K spanning amino acid 199–255 (Fig. 3). Earlier, we
constructed plasmids (Kulshreshtha et al., 2014; Fig. 2, panel A)
containing deletion of amino acid 161–200 (PC.33Kd5) and amino
acid 201–240 (PC.33Kd6). Western blot analysis conﬁrmed the
expression of variant protein in plasmid DNA transfected cells
(Fig. 2, panel B). To determine the domain involved in the
activation of MLP, the 33K mutant proteins (Fig. 2, panels A, B)
were tested for the transactivation of MLP. As seen in Fig. 2 (panel
D), deletion of amino acid 161–200 of 33K (pC.33Kd5) did not
affect the transactivation of MLP. However, the deletion of amino
acid 201–240 of 33K (pC.33Kd6) abolished the transactivation of
MLP (Fig. 2, panel D).
Activation of transcription from major late promoter by BAdV-3 22K
protein
To determine if 22K protein (unspliced form of 33K mRNA)
activate transcription from MLP, we constructed plasmids pC.22K,
pC.22Kss or pC.22KS1 (Fig. 1, panel A). The Hela cells were co
transfected with plasmid pMLP.LucþpC.33K; pMLP.LucþpC.22K;
pMLP.LucþpC.22Kss, pMLP.LucþpC. 22KS1 or pMLP.LucþpCDNA3
DNAs. As expected, there was a signiﬁcant increase in the
luciferase expression when cells were transfected with plasmid
pMLP.LucþpC.33K (Fig. 2, panel E) DNAs. However, no such
increase was observed when cells were co-transfected with
plasmid pMLP.luc and pC.22K, pC.22Kss, pC.22Ks1 or pCDNA3
(Fig. 2, panel E) DNAs.
DNA binding activity of BAdV-3 33K
Earlier reports have suggested that human adenovirus (HAdV)-
5 33K binds to intragenic sequences of MLP and stimulates
transcription (Ali et al., 2007). In particular, 33K alone bind to
DE1 sequence and in the presence of IVa2 binds to DE2A sequence
of MLP (Ali et al., 2007). The sequence alignment using CLUSTAL
W2 program demonstrated that DE1 and DE2a sequences of
intragenic regions of MLP are highly and partially conserved,
respectively between BAdV-3 and HAdV-5 (Fig. 4, panel A). To
determine if BAdV-3 33K binds to similar sequences of BAdV-3
MLP, we performed electrophoretic mobility shift assay (EMSA).
The GST alone or GST tagged 33K or 22K proteins were produced
in Escherichia coli (Kulshreshtha, 2009) and puriﬁed using
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Fig. 2. Transactivation of MLP by BAdV-3 33K. (A) Schematic representation of plasmids DNAs. The coding sequences shared by 33K and 22K ( ), unique region of 33K
( ) and the spliced region of 33K ( ) are depicted. The human cytomegalovirus immediate early promoter ( ); major late promoter (MLP). The name of
the plasmid is depicted on the right of the panel. (B, C) Western blot.Proteins from the lysates of the BAdV-3 infected MDBK cells or plasmid DNA transfected 293T cells were
separated by 10% SDS-PAGE, transferred to nitrocellulose membrane and probed with anti-33Kp sera (panel B) or anti-pIVa2 sera (panel C). The position of the molecular
weight markers (M) in kDa is shown to the left of the each panel. (D, E) Luciferase assay. Monolayers of HeLa cells were co-transfected with plasmid pMLP.luc DNA, plasmid
phRL-Renilla luciferase together with indicated individual plasmid DNAs. The cells were collected 48 h post transfection and analysed for ﬁreﬂy luciferase and renilla
luciferase activity. The ﬁreﬂy luciferase activity value was normalized by the corresponding value of Renilla luciferase. Values are expressed as relative light units (RLU).
Relative luciferase units (means from three independent experiments) are represented with corresponding standard deviations. Means with same letter are not signiﬁcantly
different *Po0.05.
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glutathione Sepharose beads (Fig. 4, panel B). The puriﬁed proteins
were used with [32P]-labeled 31 bp double stranded DNA MLP
oligonucleotide (Fig. 4, panel A) containing nucleotide 5671–5701
of BAdV-3 genome representing intragenic regions of bovine MLP
(Reddy et al., 1998) in EMSA analysis. As seen in Fig. 4, puriﬁed
33K.GST protein decreased the migration of labeled oligonucleo-
tide and formed distinct band in 4% native acrylamide gel (panel
C). No such complex was formed when puriﬁed GST alone was
used in the reaction mixture (panel C). The interaction appears
speciﬁc as increasing concentration of cold 31 bp double stranded
oligonucleotide used as a competitor decreased the binding of
puriﬁed GST-33K protein to labeled oligonucleotide (panel D).
The BAdV-3 22K protein translated from unspliced version of
33K transcript shares N-terminal 138 amino acids with 33K
protein translated from spliced 33K transcript. To determine if
22K protein bind to MLP, puriﬁed GST, 33K.GST or 22K.GST
proteins were used with [32P]-labeled 31 bp double stranded
DNA MLP oligonucleotide (Fig. 4, panel A) in EMSA. As expected,
puriﬁed 33K.GST formed complex with labeled oligonucleotide
(Fig. 4, panel E). No such complex was formed when 22K.GST or
GST alone was used in the reaction mixture (Fig.4, panel E)
DNA binding domain of BAdV-3 33K
Unlike 22K protein, since MLP activation function of 33K
appeared conserved in Mastadenoviruses, we focused on BAdV-3
33K protein particularly the region found to be highly conserved
among 33K proteins encoded by different Mastadenoviruses
(Fig. 3). To determine the MLP DNA binding domain of BAdV-3
33K, we constructed two GST tagged 33K deletions namely 33Kd6.
GST and 33Kd7.GST (Fig. 5, panel A). The tagged proteins were
expressed in Escherichia coli and individual variant 33K.GST fusion
proteins were puriﬁed using glutathione sepharose beads (Fig. 5,
panel B). Protein 33Kd6.GST contains a deletion of 201–240 amino
acids while protein 33Kd7 contains deletion contains a deletion of
amino acid 242–274. The puriﬁed, GST, 33K.GST, 33Kd6.GST, or
33Kd7d.GST proteins were used to determine their interaction
with [32P] labeled 31 bp double stranded oligonucleotide (Fig. 4,
panel A) using electrophoretic mobility shift assay (EMSA). As
expected, GST.33K formed a complex with labeled probe (Fig.5,
panel C). Similar complex was detected when 33Kd7 protein was
used with labeled probe (Fig. 5, panel C). No such complex
formation was observed in the presence of puriﬁed 33Kd6.GST or
GST alone (Fig. 5, panel C).
To conﬁrm these results, C- terminus of BAdV-3 33K encoding
amino acids 195–255 was ampliﬁed by PCR and fused in frame to
C-terminus of GAL4 activation domain containing SV40 NLS
(GADT7; Clontech) creating plasmid pC.33K.GalAD (Fig. 5, panel
D). The plasmid pMLP.Luc DNA containing a luciferase reporter
gene under the control of MLP (Fig. 5, panel D) was co-transfected
into HeLa cells together with individual plasmid pcDNA3, pC.IVa2
or pC.33K.GalAD DNAs and effect was determined using luciferase
assay. As seen in Fig. 5 (panel E), luciferase expression increased 5–
6 fold when HeLa cells were co-transfected with plasmid pMLP.
LucþpC33K. GalAD or pMLP.LucþpC.IVa2 DNAs. However, there
was no increase in the luciferase expression when plasmid pMLP.
Luc DNA was co-transfected into HeLa cells with the plasmid
pcDNA3 DNA (Fig. 5, panel E).
Leucine residues at 217, 224, 232 and 240 of BAdV-3 33K are
important for DNA binding activity.
Analysis of the highly conserved C-terminal region of BAdV-3
33K revealed that amino acids 199–255 contain 6 conserved
leucine residues (L203, L217, L224, L232, L240 and L250) (Fig. 3).
Since four of these conserved leucines (L217, L224, L232 and L240)
have spacing consistent with requirement and prediction of a
potential leucine zipper, initially we focused on these residues and
constructed mutant BAdV-3 33K containing point mutations. To
determine the importance of leucine residues of the potential
leucine zipper, leucine residue at 217, 224, 232 and 240 were
individually mutated to alanine residues. All 33K leucine variant
proteins were expressed and transported to the nucleus in
transfected cells (data not shown). Next, we constructed plasmids
containing GST tagged 33K219A, 33K224A, 33K232A or 33K240A
(Fig. 6, panel A). The individual tagged proteins were expressed in
Escherichia coli and puriﬁed using glutathione sepharose beads
(panel B). The GST-tagged variant 33K proteins were used to
determine the formation of complexes with [32P] labeled 31 bp
double stranded oligonucleotide (Fig. 4, panel A) using EMSA. As
expected 33K.GST formed complex with labeled MLP DNA probe
(Fig. 6, panel C). In contrast, like GST or 33Kd6.GST, all variant 33K
proteins generated by mutating leucine to alanine at 217, 224, 232
or 240 did not form any complex with the labeled MLP DNA probe
(Fig. 6, panel C)
To further conﬁrm these results, we ampliﬁed region spanning the
amino acids 195-255 of individual mutant 33K protein and fused in-
frame to C-terminus of GAL4 activation domain containing SV40 NLS
(GADT7; Clontech) (Fig. 7, panel A). The plasmid pMLP.Luc containing
a luciferase reporter gene under the control of major late promoter
(MLP) was co-transfected into HeLa cells together with individual
plasmid pcDNA3 or pC33K.GalAD DNA and effect was determined
using Luciferase assay. As seen in Fig. 7B, the cells co-transfected with
plasmid pMLP.Luc DNAsþpC33K.GalAD DNAs showed 2.5 fold
increase in the luciferase expression compared to the cells transfected
with plasmid pCDNA3 DNA. In contrast, there was no increase in the
luciferase expression when cells were co-transfected with plasmid,
pMLP.LucþpC33K217A.GalAD, pMLP.LucþpC33K223A.GalAD, pMLP.
LucþpC33K230A.GalAD or pMLP.LucþpC33K240A.GalAD compared
to cells co-transfected with plasmid pMLP.LucþpcDNA3 DNAs.
* **199 IFPTLYAIFQQSRAQRCHLKVKNRSLRSLTRSCLYHNKEEQLQRTLADSEALLSKYC---------------BAdV-3
85 LFPTLYAIFQQSRGSPTALKIKNRSLRSLLRSCLYHKSEEQLLRTRNDAEALLNKYC---------------CAdV-2
166 IFPTLYAIFQQSRGQEQELKIKNRSLRSLTRSCLYHKSEDQLRRTLEDAEALFSKYC---------------HAdV-2
***
203 217 224 232 240 250
167 IFPTLYAIFQQSRGQEQELKIKNRSLRSLTRSCLYHKSEDQLRRTLEDAEALFSKYC---------------HAdV-5
167 IFPTLYAIFQQSRGGQDALKIRNRTLRSLTKSCLYHREEAKLERTLSDAEALFEKYC---------------PAdV-3
137 IFPTLYAIFQQSRGQKTNLKIKNRTLRSLTKSCLYHKQESQLQRTLEDAEALLQKYC---------------OAdV-7
164 IFPTLYAIFQQSRGQEQELKIKNRSLRSLTRSCLYHKSEDQLQRTLEDAEALFNKYC---------------HAdV-35
############ ## # ### ##### # ## ## # ### ###
Fig. 3. Amino acid homology of BAdV-3 33K. Alignment of deduced amino acid sequences of BAdV-3 33K (Genbank Accession # AF030154) homologs with those of canine
adenovirus (CAdV)-2 (GeneBank Accession # AC_000020), HAdV-2 (GenBank Accession # AC_000007), HAdV-5 (GenBank Accession # AC_000008), porcine adenovirus-3
(GenBank Accession # AF083132), Ovine adenovirus-7 (GenBank Accession # NC_004037.2), HAdV-35 (GenBank Accession # AC_000019). The identical residues (#) and
Leucine residues (*) are indicated.
V. Kulshreshtha et al. / Virology 483 (2015) 174–184 177
Leucines (203,250) and arginines (211,222,225) of BAdV-3 33K are
not required for DNA binding
To determine the role of conserved leucines (203,250) which
does not appear to be part of the potential leucine zipper, we
constructed variant 33K ORFs expressing 33K containing alanine
residue in place of leucine residue at amino acid 203 (33K203A) or
at amino acid 250 (33K250A). Earlier, we also constructed a variant
33K (33Ksr) protein where arginine residues (211, 222, 225) in the
conserved RS repeat were mutated to glycine residues
(Kulshreshtha et al., 2014). To determine the role of these
conserved residues of BAdV-3 33K in binding to MLP, we con-
structed GST tagged variant 33K (Fig. 8, panel A) proteins. The
puriﬁed GST-tagged variant proteins were produced (Fig. 8, panel
B) and used to determine the formation of complexes with [32P]
labeled 31 bp double stranded oligonucleotide (Fig. 4, panel A)
using EMSA. As expected, GST (Fig. 8, panels, C, D, E), 33Kd6.GST
(Fig. 8, panel C) or 33K217A (Fig. 8, panel D) fusion proteins did not
retard the migration of the labeled DNA probe while 33K.GST
(Fig. 8, panels, C, D, E) fusion proteins retarded the migration of the
labeled DNA probe (Fig. 8, panel D). Interestingly, 33K203A.GST
(Fig. 8, panel C), 33K250A.GST (Fig. 8, panel D) or 33Ksr.GST (Fig. 8,
panel E) fusion proteins also retarded the migration of the labeled
probe when used in the reaction mixture.
To further conﬁrm these results, we ampliﬁed region spanning
the amino acids 195-255 of individual mutant 33K protein and
fused in-frame to C-terminus of GAL4 activation domain contain-
ing SV40 NLS (GADT7; Clontech) (Fig. 9, panel A). The plasmid
pMLP.Luc containing a luciferase reporter gene under the control
of major late promoter (MLP) was co-transfected into HeLa cells
together with individual plasmid pcDNA3 or pC33K.GalAD DNA
and effect was determined using Luciferase assay. As seen in
Fig. 9B, the cells co-transfected with plasmid pMLP.Luc
DNAsþpC33K.GalAD DNAs showed 3 fold increase in the lucifer-
ase expression compared to the cells transfected with plasmid
pC33K224A.GalAD DNA. Similar results were observed when
plasmid pMLP.Luc DNA was co-transfected with plasmid
pC33K203A.GalAD or pC33K250A.GalAD DNAs.
Discussion
Viral transcription regulators can act by recognizing speciﬁc
DNA sequences (Lutz et al., 1997), by interacting with cellular DNA
binding proteins, and/or by acting as cellular co-factors (Lutz and
Kedinger, 1996; Perez-Romero et al., 2005). Adenovirus intermedi-
ate protein IVa2 has been shown to bind DE sequences down-
stream of MLP and trans-activate the MLP (Lutz and Kedinger,
1996). Earlier reports have also suggested that adenovirus 33K
protein (Ali et al., 2007) is involved in the activation of MLP by
direct binding to MLP. Interestingly, adenovirus 22K protein has
also been shown to bind DE elements (Ostapchuk et al., 2006) and
stimulate transcription from MLP (Backstrom et al., 2010). In this
report, we demonstrate that (a) BAdV-3 33K activates the tran-
scription from MLP by binding to DE sequences. The DNA binding
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activity is located in the highly conserved region of BAdV-3 33K
protein, and involves leucine residues of a potential leucine zipper.
Earlier, we characterized BAdV-3 33K produced in infected or
transfected cells (Kulshreshtha et al., 2014). To characterize BAdV-
3 22K, sera raised against L6-22K produced against a peptide
representing unique region of BAdV-3 22K was used in Western
blots. Anti-22Kp serum detected two proteins of 42 kDa and
37 kDa in BAdV-3 infected cells, which could be produced due to
different post-translational modiﬁcation or initiation of translation
from different ATG codons. Surprisingly, anti-22Kp serum did not
detect such proteins in cells transfected with plasmid pC.22K DNA
with the potential to express 22K. It is possible that 22K expressed
in transfected cells is translated from a spliced mRNA. Several
observations support this prediction. First, anti-33Kp detects a
protein of 39 kDa in cells transfected with 22K expression plasmid
pC.22K DNA. Secondly, anti-33Kp detects a similar protein of
39 kDa in cells transfected with 22K expression plasmid pC.22KS1
containing insertion of a stop codon in the region spliced out in
33K. Third, anti-22Kp serum detects a protein of 42 kDa in cells
transfected with 22K expression plasmid pC.22Kss containing
mutated splice accepter/donor sites but not in cells transfected
with 22K expression plasmid pC.22K. Fourth, as expected anti-
22Kp serum did not detect any protein in cells transfected with
22K expression plasmid pC.22KS1 containing mutated splice
acceptor/donor sites and stop codon in the region spliced out in
33K. Earlier, conﬂicting observations have been reported regarding
22K of HAdV-5 (Ostapchuk et al., 2006). It has been suggested that
different molecular weight 22K could be detected due to anom-
alous migration of proteins in SDS-PAGE (Jansen-Durr et al., 1989;
Ostapchuk et al., 2006). Since 22K speciﬁc antisera has not been
used to determine the molecular weight(s) of 22K protein(s) in
HAdV-5 infected cells (Ostapchuk et al., 2006), we believe that like
BAdV-3, different forms of 22K are expressed in the HAdV-5
infected cells.
Our MLP activation and EMSA results suggest that BAdV-3 22K
does not appear to bind DE sequence and activate transcription
from MLP. In contrast, BAdV-3 33K activates transcription from
MLP by binding to DE sequences. Earlier, conﬂicting observations
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have been reported regarding the role of HAdV-5 33K and 22K in
stimulating transcription from MLP (Ali et al., 2007; Backstrom et
al., 2010) in transfected cells. Although unspliced transcript was
not detected by RT-PCR (Ali et al., 2007), it was postulated that the
plasmid expressing wild -type 33K may have produced both
spliced or unspliced transcripts expressing 33K and 22K proteins,
respectively in the transfected cell (Backstrom et al., 2010). Several
lines of evidence suggest that BAdV-3 22K protein produced from
unspliced 33K transcript is not expressed in plasmid pC.22K DNA
transfected cells. First, protein expressed in cells transfected with
plasmid pC.22K or pC.22KS1 DNA is recognized by anti-33K but
not by anti-22K serum, Secondly, no such proteins could be
detected in cells transfected with plasmid pC.22Kss DNA or
plasmid pC22KssS1 DNAs using anti-33K serum. Thirdly, 22K
speciﬁc proteins could be detected in cells transfected with
plasmid pC.22Kss DNA (where splice acceptor/donor site(s) are
altered) by anti-22K serum. Our results support the notion (Ali et
al., 2007) that protein produced in cells transfected with plasmid
with potential to express unspliced form of 33K efﬁciently produce
spliced form of protein (33K), which is stimulating transcription
from MLP.
The inability of 22K protein to bind MLP and, conservation of
the DNA binding and activation of MLP transcription function
among 33K proteins of HAdV-5 and BAdV-3 suggested that DNA
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binding domain may be present in the unique C-terminal con-
served region of 33K proteins. Analysis of 33K proteins of different
animal and human adenoviruses revealed a highly conserved
domain located between amino acid 199-255. Analysis of mutant
BAdV-3 33K proteins demonstrated that amino acids 201–240
contain MLP DNA binding domain and are critical for transcrip-
tional activity of 33K.
The leucine zipper motif has been shown to be required for
(a) DNA binding (Landschulz et al., 1988), (b) transactivation, and
repression of viral proteins (Goodwin et al., 2000), and (c) protein–
protein interaction and transactivation (Geisberg et al., 1994;
Sanchez et al., 2000). The identiﬁed conserved domain of BAdV-
3 33K protein contains 7 conserved leucines, four (217, 224, 232,
240) of which appear to have conﬁguration consistent with a
potential leucine zipper motif (amino acids 217–240; Fig.3). Our
results suggest that individual leucine residues of the putative
leucine zipper motif appear essential for DNA binding and sub-
sequent activation of transcription from MLP. Moreover, the
function of activation of MLP by binding to DE elements appears
conserved among 33K proteins of Mastadenoviruses.
Material and methods
Production of antisera
A peptide (amino acid191CRPEADQNRHSEQKEPPECQRGAPSPSSS
SSQACSG APPPQRPAPSGRRRK241) representing 22K was synthe-
sized on the Pioneer Peptide Synthesis system (Perkin Elmer) and
conjugated to keyhole limpet hemocyanin (KLH) as a carrier mole-
cule. Rabbits were immunized with conjugated peptide (500 μg/
rabbit) emulsiﬁed with Freund's Complete Adjuvant (FCA) followed
by two injections (conjugated peptide, 250 μg/rabbit) in Freund's
incomplete adjuvant (FIA) at four weeks apart. Serum was collected
twelve days after the third injection to test for protein speciﬁc
antibodies.
Construction of plasmids
The construction of plasmids pC.33K (spliced 33K), pC.22K,
(unspliced 33K), pC.33KD5, pC.33Kd6 and pC.33Ksr is described
elsewhere (Kulshreshtha et al., 2014). The construction of pC.IVA2
(contain IVa2 gene under the control of CMV promoter), and pMLP.
Luc (contains ﬁreﬂy luciferase gene under the control of adeno-
virus major late promoter) will be described elsewhere.
Plasmids expressing 22K.
(i) pC.22K. A 835 bp fragment was ampliﬁed by PCR using
primers P20 and P37 Table 1), and plasmid DNA pSM12
(Kulshreshtha et al., 2004) DNA as a template. The PCR
fragment was digested with SacII–EcoRI and ligated to 5.4 kb
SacII–EcoRI fragment of plasmid pC.33K creating plasmid
pC.22K.
(ii) pC.22Kss. A 425 bp fragment was ampliﬁed by PCR using the
primers P20 and P35 and plasmid pC.22K DNA as a template.
Similarly, a 600 bp fragment was ampliﬁed from by PCR using
the primers P22 and P36 (Table 1), and plasmid pC.22K DNA
as a template. In a third PCR reaction, both ampliﬁed frag-
ments were annealed and external primers P20 and P37
(Table 1) were used to PCR across to give a 840 bp amplicon.
This PCR product was digested with SacII–EcoRI and ligated to
SacII–EcoRI digested pC.33K creating plasmid pC22Ks (splice
donor site GT removed to GC).
A 580 bp fragment was ampliﬁed from by PCR using the
primers P20 and P38 (Table 1), and plasmid pC.22Ks DNA as a
template. Similarly, a 427 bp fragment was ampliﬁed from by
PCR using the primers P22 and P39 (Table 1), and plasmid
pC.22Ks as a template. In a third PCR reaction, both ampliﬁed
fragments were annealed and external primers P20 and P37
(Table 1) were used to PCR across to give a 840 bp amplicon.
This PCR product was digested with SacII–EcoRI and ligated to
SacII–EcoRI digested pC.22K creating plasmid pC.22Kss (splice
donor and splice acceptor site mutated).
(iii) pC.22KS1. A 835 bp NdeI–EcoRI fragment ampliﬁed by PCR
using primers P20 and P37 (Table 1), and plasmid pSM12
(Kulshreshtha et al., 2004) DNA as a template and ligated to
7.2 kb NdeI–EcoRI digested plasmid pGBKT7 (Clontech) creat-
ing plasmid pGBK-22. A 8.1 kb NcoI fragment (blunt end
repaired by T4 polymerase) of pGBKT7.22 K was ligated to a
XbaI linker (containing three way stop codon) creating the
plasmid pGBKT7.22Ks. A 310 bp PshAI–AscI fragment of plas-
mid pGBKT7.22Ks and ligated to 5.9 kb PshAI–AscI fragment of
pC.22K creating the plasmid pC.22KS1.
Plasmids expressing mutant 33K
(i) Plasmid pC.33K203A. A 1 kb DNA fragment was ampliﬁed
using primers P1 and P7 (Table 1), and plasmid
pGEX.33K203A DNA as a template. The PCR product was
digested with EcoRI–NotI and ligated to EcoRI–NotI digested
pCDNA3 creating plasmid pC.33K203A.
(ii) Plasmid pC.33K217A. A 650 bp fragment was ampliﬁed from by
PCR using the primers P20 and P40 (Table 1) and plasmid
pC.33K DNA as a template. Similarly, a 356 bp fragment was
ampliﬁed by PCR using the primers P21 and P41 (Table 1) and
plasmid pC.33K DNA as a template. In a third PCR reaction,
two PCR fragments that have 21 bp of internal overlap were
annealed and external primers P1 and P21 (Table 1) were
used to PCR across to give a 1 kb amplicon. This PCR product
Table 1
List of primers.
P1 50-ACTGACGAATTCATGAAACCCCGCAGCATGTC-30
P2 50-GGAATATGGCATAAGCAGTGGGAAAGATC-30
P3 50-GATCTTTCCCACTGCTTATGCCATATTCC-30
P4 50-ACTGACGTCGACAGGGACGGATTCGTCCTT-30
P5 50-CAGTATTTACTGAGAGCCGCCTCGGAGTCTG-30
P6 50-AGACTCCGAGGCGGCTCTCAGTAAATACTG-30
P7 50-ACTGACGCGGCCGCTCAAGGGACGGATTCGTCCTT-30
P20 50-GGAATTCCATATGATGAAACCCCGCAGCATGTCG-30
P21 50-GGAATTCTTAGGCGGGTCCGGATTCG-30
P22 50-GAAGGCACAGTCGAGGCT-30
P35 50-GCTCCTCTTGCCTCTAGCGCC-30
P36 50-GCTAGAGGCAAGAGGAGCTAC-30
P37 50-GGAATTCCTATTTTTCACTTTGAGGTG-30
P38 50-TTCGGGTCGGCAGTAAGAATT-30
P39 50-TCTTACTGCCGACCCGAAGC-30
P40 50-TTTCACTTTGGCGTGACACCGC-30
P41 50-CGGTGTCACGCCAAAGTGAAAAAT -30
P42 50-CAGTGAACGTGCGGATCTATTTTTC-30
P43 50-AATAGATCCGCACGTTCACTGACG-30
P44 50-GTTGTGGTAGGCGCAGCTGCG-30
P45 50-CGCAGCTGCGCTACCCACAAC-30
P46 50-GGTTCGCTGGGCCTGTTCCTC-30
P47 50-GAGGAACAGGCCCAGCGAACC-30
P48 50-CGGAATTCCTTCGGGAGCTGATCTTTCCC-30
P49 50-ACTGACGTCGACAGGGACGGATTCGTCCTT-30
P50 50-CGGAATTCCTTCGGGAGCTGATCTTTCCC-30
P51 50-CCGCTCGAGTCAGCAGTATTTACTGAG-30
P52 50-ACTGACGAATTCATGAAACCCCGCAGCAT
P53 50-ACTGACGTCGACACTTTGAGGTGACACCG
Restriction enzyme recognition sites are underlined and in italics.
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was digested with SacII–EcoRI and ligated to SacII–EcoRI
digested pC.33K creating plasmid pC.33K217A (Fig. 6A).
(iii) Plasmid pC.33K224A. A 672 bp fragment was ampliﬁed from
by PCR using the primers P20 and P42 (Table 1), and plasmid
pC.33K DNA as a template. Similarly, a 334 bp fragment was
ampliﬁed by PCR using the primers P21 and P43 (Table 1), and
plasmid pC.33K DNA as a template. In a third PCR reaction,
two PCR fragments that have 21 bp of internal overlap were
annealed and external primers P20 and P21 (Table 1) were
used to PCR across to give a 1 kb amplicon. This PCR product
was digested with SacII–EcoRI and ligated to SacII–EcoRI
digested plasmid pC.33K creating plasmid pC.33K224A
(Fig. 6A).
(iv) Plasmid pC.33K232A. A 695 bp fragment was ampliﬁed from
by PCR using the primers P20 and P44 (Table 1), and plasmid
pC.33K DNA as a template. Similarly, a 311 bp fragment was
ampliﬁed by PCR using the primers P45 and P21 (Table 1), and
plasmid pC.33K DNA as a template. In a third PCR reaction,
two PCR fragments that have 19 bp of internal overlap were
annealed and external primers P20 and P21 (Table 1) were
used to PCR across to give a 1 kb amplicon. This PCR product
was digested with SacII–EcoRI and ligated to SacII–EcoRI
digested plasmid pC.33K creating plasmid pC.33K232A
(Fig. 6A).
(v) Plasmid pC.33K240A. A 717 bp fragment was ampliﬁed from by
PCR using the primers P20 and P46 (Table 1), and plasmid
pC.33K DNA as a template. Similarly, a 289 bp fragment was
ampliﬁed by PCR using the primers P21 and P47 (Table 1), and
plasmid pC.33K DNA as a template. In a third PCR reaction,
two PCR fragments that have 21 bp of internal overlap were
annealed and external primers P20 and P21 (Table 1) were
used to PCR across to give a 1kp amplicon. This PCR product
was digested with SacII–EcoRI and ligated to SacII–EcoRI
plasmid pC.33K digested plasmid pC.33K creating plasmid
pC.33K240A (Fig. 6A).
(vi) Plasmid pC.33K250A. A 1 kb DNA fragment was ampliﬁed
using primers P1 and P7 (Table 1), and plasmid
pGEX.33K250A DNA as template. The PCR fragment was
digested with EcoRI–NotI and ligated to EcoRI–NotI digested
plasmid pCDNA3 creating plasmid pC.33K250A
Plasmids expressing GST fusion
The construction of plasmid pGEX.33K has been described
earlier (Kulshreshtha and Tikoo, 2008). A 850 bp DNA fragment
ampliﬁed by PCR using primers P48 and P49 (Table 1), and
individual plasmid (pC.33K217A; pC.33K224A; pC.33K232A;
pC.33K240A, pC.33Kd6, pC.33Kd7; pC.33Ksr) DNA a template.
The PCR ampliﬁed DNA fragments were individually digested with
EcoRI–SalI and ligated to EcoRI–SalI digested plasmid pGEX-5X-1
creating plasmids pGEX.33K217A, pGEX.33K224A, pGEX. 33K232A,
pGEX.33K240A, pGEX.33Kd6, pGEX33Kd7 and pGEX.33Ksr,
respectively.
A 839 bp DNA fragment ampliﬁed by PCR using primers P52
and P53, and plasmid pC.22K DNA as a template. The PCR
ampliﬁed DNA fragment was digested with EcoRI–SalI and ligated
to EcoRI–SalI digested plasmid pGEX-5X-1 creating plasmid
pGEX.22K.
A 622 bp DNA fragment was ampliﬁed by PCR using the
primers P1 and P2 (Table 1), and plasmid pGEX.33K DNA as a
template. Similarly, 241 bp fragment was ampliﬁed by PCR using
primers P3 and P4 (Table 1), and plasmid pGEX.33K DNA as a
template. In third PCR, two PCR fragments that have 29 bp of
internal overlap were annealed and external primers P1 and P4
(Table 1) were used to PCR across to give 1 kb amplicon. This PCR
product was digested with EcoRI-SalI and ligated to EcoRI–SalI
digested plasmid pGEX.33K creating plasmid pGEX.33K203A.
A 764 bp DNA fragment was ampliﬁed by PCR using the
primers P1 and P5 (Table 1), and plasmid pGEX.33K DNA as a
template. Similarly, 100 bp fragment was ampliﬁed by PCR using
primers P4 and P6 (Table 1), and plasmid pC.33 K DNA as a
template. In third PCR, two PCR fragments that have 30 bp of
internal overlap were annealed and external primers P1 and P4
were used to PCR across to give 1 kb amplicon. This PCR product
was digested with EcoRI–SalI and ligated to EcoRI–SalI digested
plasmid pGEX.33K creating plasmid pGEX.33K250A.
Plasmids expressing Gal activation domain fusions
A 510 bp HindIII–EcoRI fragment (containing Gal activation
domain fused to SV40 NLS and HA epitope) of plasmid pGADT7
was isolated and ligated to 5.4 kb HindIII–EcoRI digested plasmid
pcDNA3 creating plasmid pC.galAD. DNA fragments (190 bp each)
were ampliﬁed by PCR using primers P50 and P51 (Table 1), and
individual plasmid (pC.33K, pC.33K203A, pC.33K217A, p33K.224A,
pC.33K232A, pC.33K240A or pC.33K250A) as DNA templates. The
individual PCR fragment was digested with EcoRI–XhoI and ligated
to EcoRI–XhoI digested pC.GalAD creating plasmids pC33K.GalAD,
pC33K203A, pC33K217A.GalAD, pC33K224A.GalAD, pC33K232A.
GalAD, pC33K240A.GalAD and pC33K250A.GalAD.
Production of GST fusion proteins
The expression of individual GST fusion proteins was induced
in Escherichia coli by IPTG (1 M) for 5 h and fusion proteins were
puriﬁed using GST-beads following the manufacturer's protocol.
The purity of GST fusion proteins was checked by Coomassie
staining of SDS-PAGE gels. Protein concentration was determined
by Bradford protein assay.
Transcriptional activation assay.
Cells in one well (1.2105 cells/well) of a 6 well plate were co-
transfected with 20 ng of plasmid phRL-Renilla luciferase DNA,
1.5 μg/well of pMLP.Luc DNA and 500 ng of individual effector
plasmid using lipofectamine 2000 (Invitrogen) as suggested by the
manufacturer. Cells were lysed after 48 h of transfection and ﬁrely
luciferase and Renilla luciferase activity were measured by TD 20/
20 luminometer (Turner Designs Instrument) using the kit (Pro-
mega) according to the manufacturer's protocol. The ﬁreﬂy luci-
ferase activity value was normalized by the corresponding value of
Renilla luciferase.
Electrophoretic mobility shift assay
Two complementary oligonucleotides 31bases long containing
50 overhangs (50-ctagg TTGTCAGTTTCCAC GAAGGCGGTGCTTT TGA-
30; 50-ctaggTCAAAAGCAC CGCCTTCGTGGAAACTGACAA-30) repre-
senting BAdV-3 major late promoter sequences were annealed.
The 50 overhang was ﬁlled with dNTPs (dATP, dGTP, dTTP and α-
dCTP32) using T4 DNA polymerase. Un-incorporated nucleotides
were removed using phenol-chloroform extraction and labeled
oligos were recovered by ethanol precipitation. The intensity of
labeled oligos was determined by liquid scintillation counter
(Backman). About 10,000 cpm labeled oligo was applied in this
experiment to explore the binding of BAdV-3 33K protein in the
MLP region. EMSAwas performed following the protocol described
earlier with little modiﬁcation (Ali et al., 2007). The labeled oligo
(1000 cpm) and 500 ng protein were incubated in the binding
buffer for 20–30 min. The reaction mixture was run on 4%
acrylamide native gel for 3 h at 150 V. The gel was dried on
V. Kulshreshtha et al. / Virology 483 (2015) 174–184 183
Whatman paper and exposed over night on a phosphor-imaging
screen. The image was analyzed by Molecular Imager (BioRad).
Empty GST fusion protein was used as a control in this experiment.
The binding of 33K protein in the MLP region was conﬁrmed by
competitive binding assay using unlabeled oligonucleotides.
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